Explore insights and strategies for managing ATTR-CM long-term.
-
-
When fatigue steals the life you want to live
-
Serum transthyretin levels may predict tafamidis therapy outcomes in ATTR-CM
-
FDA removes hold on clinical trial for nex-z in ATTR-CM
-
Heavy physical labor may increase risk of wild-type ATTR-CM, study suggests
-
How to ‘Light Up for Rare’ on Rare Disease Day
-
Picking up where he left off: Why our family won’t stop fighting ATTR